Multimodal Pathologic Diagnosis of Malignant Melanoma: Integration of Morphology, Histochemistry , Immunohistology, and Electron Microscopy

References

• Nakhleh RE, Wick MR, Rocamora A, Swanson PE, Dehner LP: Morphologic diversity in malignant melanomas. Am J Clin Pathol 93:731–740, 1990
   PubMed Web of Science ®Google Scholar
• Banerjee SS, Harris M: Morphologic and immunophenotypic variation in malignant melanoma. Histopathology 36:387–402, 2000
   PubMed Web of Science ®Google Scholar
• Reed RJ, Martin P: Variants of melanoma. Semin Cutcut Med Surg 16:137–158, 1997
   PubMed Web of Science ®Google Scholar
• Szodoray L, Nagy-Vezekenyi C: Histochemical studies on melanotic proliferations. Dermatol Wochenschr 151:2006–2015, 1965
   PubMedGoogle Scholar
• Tarkkanen A, Niemi M: Application'of enzyme histochemical methods in the differential diagnosis of melanoma and leio-myoma of the iris. Acta Pathol Microbiol Scat& 70:53–57, 1967
   PubMedGoogle Scholar
• Qizilbash AH, Liao SK, Dent PB: Characterization of human malignant melanoma cell lines. IV. Cytologic & histochemical characteristics. Acta Cytol 21:147–150, 1977
   PubMed Web of Science ®Google Scholar
• Carson F: Histotechnology, 2nd ed. ASCP Press, Chicago, 1997, pp 211–215
   Google Scholar
• Okun MR, Edelstein L, Niebauer G, Hamada G: The histo-chemical tyrosine-dopa reaction for tyrosinase and its use in localizing tyrosinase activity in mast cells. J Invest Dermatol 53:39–45, 1969
   PubMed Web of Science ®Google Scholar
• Hewitt J, Guigon M, Bolubasz J, Masson C: Beta-glucuron-idase activity in pigmented tumors of the human skin: histo-chemical and biochemical study. Rev Eur Etud Clin Biol 15: 416–423, 1970
   PubMedGoogle Scholar
• Paul E: Histochemical findings in different types of malignant melanoma: biological and clinical significance. Arch Derma-to/ Res 254:159–174, 1975
   PubMed Web of Science ®Google Scholar
• Bedrick AE, Ramasamy G, Tchertkoff V: Histochemical de-terminations of copper, zinc, and iron in pigmented nevi and melanoma. Am J Dermatopathol 13:575–578, 1991
   PubMed Web of Science ®Google Scholar
• Gibson LE, Goellner JR: Amelanotic melanoma: cases studied by Fontana stain, S100 immunostain, and ultrastructural ex-amination. Mayo Clin Proc 63:777–782, 1988
   PubMed Web of Science ®Google Scholar
• Osborn M: Intermediate filaments as histologic markers: an overview. J Invest Dermatol 81(Suppl 1):104s-109s, 1983
   PubMed Web of Science ®Google Scholar
• Ramaekers FCS, Puts JJ, Moesker O, et al: Intermediate fila-ments in malignant melanomas: identification and use as a marker in surgical pathology. Jain Invest 71:635–643, 1983
   Google Scholar
• Caselitz J, Janner M, Breitbart E, Weber K, Osborn M: Malignant melanomas contain only the vimentin type of interme-diate filaments. Virchows Arch A 400:43–51, 1983
   Web of Science ®Google Scholar
• Zarbo RJ, Gown AM, Nagle RB, Visscher DW, Crissmen JD: Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional Western blot analysis and immu-nohistochemical survey of 100 melanomas. Mod Pathol 3: 494–502, 1990
   PubMed Web of Science ®Google Scholar
• Miettinen M, Franssila K: Immunohistochemical spectrum of malignant melanoma: the common presence of keratins. Lab Invest 61:623–628, 1989
   PubMed Web of Science ®Google Scholar
• Wick MR: Immunohistologic features of melanocytic neo-plasms. In Diagnostic Inummohistochemistry, Dabbs DJ (ed.), Churchill-Livingston, New York, 2002, pp 147–162
   Google Scholar
• Gaynor R, Herschman HR, Irie R, Jones P, Morton D, Cochran A: S100 protein: a marker for human malignant melanomas? Lancet 1:869-871, 1981
   PubMed Web of Science ®Google Scholar
• Cochran AJ, Lu HF, Li PX, Saxton R, Wen DR: S100 protein remains a practical marker for melanocytic and other tumors. Melanoma Res 3:325–330, 1993
   PubMed Web of Science ®Google Scholar
• Takahashi K, Isobe T, Ohtsuki Y, Akagi T, Sonobe H, Okuyama T: Immunohistochemical study on the distribution of alpha and beta subunits of S100 protein in human normal and neoplastic tissues. Virchows Arch B 45:385–396, 1984
   Google Scholar
• Herrera GA, Pena JR, Turbat-Herrera EA, Kelly DR, Shultz JJ: The diagnosis of melanoma: current approaches addressing tumor differentiation. Pathol Anntt 29(Part 1):233–260, 1994
   PubMedGoogle Scholar
• Ribe A, McNutt NS: S100A6 protein expression is different in Spitz nevi and melanomas. Mod Pathol 16:505–511, 2003
   PubMed Web of Science ®Google Scholar
• Smoller BR: Immunohistochemistry in the diagnosis of mela-nocytic neoplasms. Pathol State Art Rev 2:371–383, 1994
   Google Scholar
• Yaziji II, Gown AM: Immunohistochemical markers of me-lanocytic tumors. hit J Surg Pathol 11:11–15, 2003
   PubMed Web of Science ®Google Scholar
• Mangini J, Li N, Bhawan J: Immunohistochemical markers of melanocytic lesions: a review of their diagnostic usefulness. Am J Dermatopathol 24:270–281, 2002
   PubMed Web of Science ®Google Scholar
• Kawakami Y, Nishimura MI, Restifo NP, et al: T-cell recog-nition of human melanoma antigens. J lmmunother 14:88–93, 1993
   PubMed Web of Science ®Google Scholar
• Adema GJ, deBoer AJ, van't Hullenaar R, Denijn M, Ruiter DJ, Vogel AM, et al: Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathol 143:1579–1585, 1993
   PubMed Web of Science ®Google Scholar
• Fetsch PA, Fetsch JF, Marincola FM, Travis W, Batts KP, Abati A: Comparison of melanoma antigen recognized by T-cells (MART-1) to HMB-45: additional evidence to support a common lineage for angiomyolipoma, lymphangiomyoma-tosis, and clear cell sugar tumor. Mod Pathol 11:699–703, 1998
   PubMed Web of Science ®Google Scholar
• Ribalta T, Lloreta J, Munne A, Serrano S, Cardesa A: Malig-nant pigmented clear cell epithelioid tumor of the kidney: clear cell ("sugar") tumor versus malignant melanoma. Hum Pathol 31:516–519, 2000
   PubMed Web of Science ®Google Scholar
• Loy TS, Phillips RW, Linder CL: A103 immunostaining in the diagnosis of adrenal cortical tumors: an immunohistochemical study of 316 cases. Arch Pathol Lab Med 126:170–172, 2002
   PubMed Web of Science ®Google Scholar
• Koch MB, Shih IM, Weiss SW, Folpe AL: Microphthalmia transcription factor and melanoma cell adhesion molecule ex-pression distinguish desmoplastic/spindle-cell melanoma from morphologic mimics. Am J Surg Pathol 25:58–64, 2001
   PubMed Web of Science ®Google Scholar
• King R, Googe PB, Weilbaecher KN, Mihm MC, Jr, Fisher DE: Microphthalmia transcription factor expression in cuta-neous benign and malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol 25:51–57, 2001
   PubMed Web of Science ®Google Scholar
• King R, Weilbaecher KN, McGill G, Cooley E, Mihm M, Fisher DE: Microphthalmia transcription factor: a sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol 155:731–738, 1999
   PubMed Web of Science ®Google Scholar
• Miettinen M, Fernandez M, Franssilak K, Gatalica Z, Lasota J, Sarlomo-Rikala M: Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am J Surg Pathol 25:205–211, 2001
   PubMed Web of Science ®Google Scholar
• Granter SR, Weilbaecher KN, Quigley C, Fletcher CDM, Fisher DE: Microphthalmia transcription factor: not a sensi-tive or specific marker for the diagnosis of desmoplastic mela-noma and spindle-cell (non-desmoplastic) melanoma. Am J Dermatopathol 23:185–189, 2001
   PubMed Web of Science ®Google Scholar
• Orchard G: Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail. Br J Biomed Sci 59: 196–202, 2002
   PubMedGoogle Scholar
• Shidham VB, Qi D, Rao RN, Acker SM, Chang CC, Kampalath B, et al: Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous mela-noma with "MCW Melanoma Cocktail"—a mixture of mono-clonal antibodies to MART-1, melan-A, and tyrosinase. BMC Cancer 3:15 (E-publication), 2003
   Google Scholar
• Ordonez NG, Mackay B: Electron microscopy in tumor diag-nosis: indications for its use in the immunohistochemical era. Hum Pathol 29:1403–1411, 1998
   PubMed Web of Science ®Google Scholar
• Herrera GA, Turbat-Herrera EA: Current role of electron mi-croscopy in the diagnosis of pigmented tumors. Semin Diagn Pathol 20:60–71, 2000
   Google Scholar
• Erlandson RA: Diagnostic Transmission Electron Microscopy of Tumors, Raven Press, New York, 1994, pp 515–523
   Google Scholar
• Min KW: Usefulness of electron microscopy in the diagnosis of small round cell tumors of the sinonasal region. Ultrastruct Pathol 19:347–363, 1995
   PubMed Web of Science ®Google Scholar
• Bhuta S: Electron microscopy in the evaluation of melanocytic tumors. Semin Diagn Pathol 10:92–101, 1993
   PubMed Web of Science ®Google Scholar
• Young NA, Naryshkin S, Katz SM: Diagnostic value of elec-tron microscopy on paraffin-embedded cytologic material. Di-agn Cytopathol 9:282–290, 1993
   PubMed Web of Science ®Google Scholar
• Mazur MT, Katzenstein AL: Metastatic melanoma: the spec-trum of ultrastructural morphology. Ultrastruct Pathol 1:337–356, 1980
   PubMed Web of Science ®Google Scholar
• Dar AU, Hird PM, Wagner BE, Underwood JC: Relative use-fulness of electron microscopy and immunocytochemistry in tumor diagnosis: 10 years of retrospective analysis. J Clin Pathol 45:693–696, 1992
   PubMed Web of Science ®Google Scholar
• Lombardi L, Orazi A: Electron microscopy in an oncologic institution: diagnostic-usefulness in surgical pathology. Tu-mor 74:531–535, 1988
   PubMed Web of Science ®Google Scholar
• Azar HA, Espinoza CG, Richman AV, Saba SR, Wang T: "Undifferentiated" large-cell malignancies: an ultrastructural and immunocytochemical study. Hum Pathol 13:323–333, 1982
   PubMed Web of Science ®Google Scholar
• Erlandson RA: Ultrastructural diagnosis of amelanotic malig-nant melanoma: aberrant melanosomes, myelin figures, or ly-sosomes? Ultrastruct Pathol 11:191–208, 1987
   PubMed Web of Science ®Google Scholar
• Carstens PHB, Kuhns JG: Ultrastructural confirmation of ma-lignant melanoma. Ultrastruct Pathol 2:147–149, 1981
   PubMed Web of Science ®Google Scholar
• Szpak CA, Shelburne J, Linder J, Klintworth GK: The pres-ence of stage II melanosomes (premelanosomes) in neoplasms other than melanomas. Mod Pathol 1:35–43, 1988
   PubMed Web of Science ®Google Scholar